JP

John Prix Mascarenhas

Active Director Director DIN 10685952
DIN 10685952 First appointment Jun 2024
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2024
Shareholding value •••• Premium profile

About John Prix Mascarenhas

Data last updated:

John Prix Mascarenhas is a Director at Insulingate Private Limited (since 2024). Insulingate Private Limited reported revenue of ₹37,976 (FY 2025).

DIN 10685952
Primary Designation Director
First Appointment 27 Jun 2024
Oldest Company Age 2 yrs
Largest company Insulingate Private Limited · ₹37,976 (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Insulingate Private Limited U62013TN2024PTC171455
Director27 Jun 20242024₹37,976 (FY 2025)Active

Board colleagues of John Prix Mascarenhas

NameDINCompanyDesignation
Barnabas Cangan Alphonsal10685953Insulingate Private LimitedDirector

Directorship timeline

Open interactive timeline →
Insulingate Private Limited
Premium access

Shareholding and investment profile for John Prix Mascarenhas

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about John Prix Mascarenhas

John Prix Mascarenhas currently holds 1 directorship: Insulingate Private Limited (Director, since 27 Jun 2024, revenue ₹37,976 (FY 2025)).

John Prix Mascarenhas was first appointed on 27 Jun 2024 as Director at Insulingate Private Limited.

The current boards of John Prix Mascarenhas's companies include Barnabas Cangan Alphonsal (Insulingate Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available